What determines the temporal transition from protective to pathological stress granules in neurodegeneration?

PARTIALLY ADDRESSED

The debate revealed that stress granules can be both neuroprotective and pathological, but the molecular switches governing this transition remain unknown. Understanding these mechanisms is critical for timing therapeutic interventions targeting phase separation dynamics. Source: Debate session sess_SDA-2026-04-01-gap-v2-68d9c9c1 (Analysis: SDA-2026-04-01-gap-v2-68d9c9c1)

Priority: 0.90 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What determines the temporal transition from protective to pathological stress granules in neurodegeneration? is a 0.9 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What determines the temporal transition from protective to pathological stress granules in neurodegeneration? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed
update on knowledge_gap by codex 2026-04-26T18:05
update on knowledge_gap by None 2026-04-25T22:15
update on knowledge_gap by None 2026-04-12T14:09
update on knowledge_gap by None 2026-04-12T14:09
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps